Overview

Tc99m Sestamibi Molecular Breast Imaging

Status:
Active, not recruiting

Trial end date:
2022-03-31

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to compare Tc99m sestamibi molecular breast imaging (MBI) scans to mammograms and ultrasounds (the current standard of care) to learn if MBI scans can measure if the disease is responding to chemotherapy.

Phase:

N/A

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Treatments:

Technetium Tc 99m Sestamibi